Apr 10 |
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion
|
Apr 10 |
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal
|
Apr 10 |
Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal
|
Apr 10 |
UPDATE 3-Vertex Pharma bets on kidney disease treatment with $4.9 bln Alpine Immune deal
|
Apr 10 |
Vertex enters into agreement to acquire Alpine Immune Sciences
|
Apr 10 |
Vertex Enters Into Agreement to Acquire Alpine Immune Sciences
|
Apr 10 |
Vertex to buy kidney disease drugmaker Alpine for $4.9B
|
Apr 10 |
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
|
Apr 9 |
Vertex to Announce First Quarter 2024 Financial Results on May 6
|
Apr 9 |
This Growth Stock Is One Step Closer to Launching a New Blockbuster: Time to Buy?
|